YorkTest Laboratories Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

YorkTest Laboratories Limited - overview

Established

1982

Location

-, -, UK

Primary Industry

Healthcare

About

Based in the UK, YorkTest Laboratories Limited specializes in advanced food intolerance and allergy testing, offering home blood test kits for individuals to identify dietary sensitivities. YorkTest Laboratories Limited is a health testing company founded in 1982 in Huntington, UK. The company is led by CEO Richard Dawson and has secured GBP 10. 000 mn in funding from NVM Private Equity in July 2022.


The funding will support the launch of 10 new home health tests and expansion into new markets, including the US. The company has closed a total of 3 deals to date, with its most recent deal occurring on July 26, 2022. YorkTest specializes in food intolerance and allergy testing, providing home blood test kits that help individuals identify sensitivities to various food and drink items. Their flagship products include the Premium Food Intolerance Test, which analyzes reactions to 200 food items, and the Food Allergy Test for assessing potential allergic reactions.


The tests aim to address health issues such as IBS, bloating, and fatigue, enabling customers to enhance their dietary choices and overall health. With over 40 years of expertise in health testing, YorkTest serves both individual consumers and nutritional practitioners, primarily focusing on the UK and European markets. In the most recent fiscal year of 2018, YorkTest reported a revenue of GBP 5,066,453. 20.


The company generates income through direct-to-consumer sales of its testing kits and associated consultation services, offering results online within seven days. The Premium Food Intolerance Test is priced at GBP 139, while the Food Allergy Test costs GBP 230, with additional bundled options available for comprehensive testing. YorkTest Laboratories Limited plans to utilize the GBP 10. 000 mn investment from NVM Private Equity to develop and launch 10 new home health tests.


The company aims to expand into the US market and enhance its laboratory capabilities. These initiatives are expected to commence following the most recent funding round completed in July 2022.


Current Investors

NVM Private Equity, Key Capital Partners

Primary Industry

Healthcare

Sub Industries

Diagnostic, Medical & Imaging Laboratories

Website

www.yorktest.com

Company Stage

Mature

Total Amount Raised

Subscriber access only

YorkTest Laboratories Limited - financials

Fiscal Year EndedDec 31, 2013Dec 31, 2014Dec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022
Revenue (USD)2,605,001-2,945,2183,743,9604,045,9123,795,271----
% Revenue Growth (YoY)---27.1%8.1%(6.2%)----
EBITDA (USD)125,799-439,152905,415301,982(580,409)----
Operating Income (USD)43,027-370,960857,883255,678(654,571)----
Operating Margin1.7%-12.6%22.9%6.3%(17.2%)----
% EBITDA Margin4.8%-14.9%24.2%7.5%(15.3%)----
NET Income (USD)38,450-295,113723,434203,605(698,919)----
% Net Margin1.5%-10.0%19.3%5.0%(18.4%)----

YorkTest Laboratories Limited - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
GrowthCompletedYorkTest Laboratories Limited-
Secondary BuyoutCompletedYorkTest Laboratories Limited-
Add-onCompletedYorkTest Laboratories Limited-

Displaying 1 - 3 of 3

YorkTest Laboratories Limited - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.